Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma

The P-values for the comparisons shown in Figure 10 and reported in the text were not controlled for alpha error. We used Hochberg’s method (the modified Bonferroni method) for P-value correction; the main results remain the same after this correction, but the Article now reports adjusted P-values. The Article changed as follows. The original Figure 10 and accompanying legend appear below. Figure 10 Kaplan–Meier survival plots of ( a ), MBZ vs. DEN; ( b ), SO vs. DEN; ( c ), MBZ + SO vs. DEN; ( d ), MBZ + SO vs. SO; ( e ), MBZ + SO vs. MBZ and ( f ), survival proportions between treatment groups. Statistical analysis was done using the log rank test (Mantel-cox method). P values < 0.05 were considered significant. Full size image